ArticleFrontiers in cardiovascular medicine2025
Predictive value of echocardiographic parameter of diastolic dysfunction (Ea/Aa) combined with electrocardiographic P-wave dispersion for the detection of early recurrence of atrial fibrillation after radiofrequency catheter ablation.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Smoking and Risk of Atrial Fibrillation Recurrence After Catheter Ablation: A Meta-Analysis and Meta-Regression.Journal of arrhythmia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the predictive value of echocardiographic parameters of left-ventricular diastolic function combined with electrocardiographic P-wave dispersion (PWD) for early recurrence of atrial fibrillation (ERAF) after radiofrequency catheter ablation (RFCA). Methods: A total of 145 patients with atrial fibrillation who underwent their first RFCA at the Department of Cardiology, First Affiliated Hospital of Hainan Medical University, between January 2021 and December 2024, were enrolled in the study. The patients were followed up for 3 months after RFCA and divided into two groups, namely those with early recurrence and those without early recurrence. Within 2 h after the procedure, 12-lead electrocardiogram (ECGs) was recorded. The maximum P-wave duration (Pmax), minimum P-wave duration (Pmin), and PWD (the difference between Pmax and Pmin) were measured. Additionally, left-ventricular diastolic function parameters were obtained via echocardiography. Results: ECG monitoring revealed ERAF in 45 patients (31.03%) at 3-month follow-up after RFCA. Spearman correlation analysis showed that ERAF positively correlated with PWD ( Conclusion: Left-ventricular diastolic dysfunction parameters and PWD can effectively predict ERAF after RCAF. Ea/Aa < 1 and PWD ≥ 29.5 ms are strong and independent predictors of ERAF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.